Business
SBC Medical Group Holdings Announces Approval of Share Repurchase Program and Commencement of Share Repurchases
IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, “the Company”) today announces that its Board of Directors has

About this update from Sbc Medical Group Holdings Incorporated
[{"type":"text","content":"IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, “the Company”) today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025. Share Repurchase Program Maximum aggregate amount: US $5 millionImplementation period: May 20, 2025 – May 20, 2026Funding source: Surplus cash and future free cash flow The Company believes its current share price undervalues its business performance, the growth potential of the aesthetic‑medical market, and its position as an industry leader. Based on this view, it has decided to purchase shares on the open market at prevailing market prices (including through Rule 10b5-1 plans) and the Company will continue to explore additional measures to enhance liquidity of its shares. The Company expects to issue shares as future stock‑based compensation in proportion to the number of repurchased shares. To maximize shareholder value, the Company will pursue a balanced approach between growth investment and shareholder returns. In addition to the repurchase program, it will continue to consider dividend distributions with the goal of improving its total shareholder return. To allocate funds to this repurchase, the Company has decided to defer further purchases under the Bitcoin purchase plan (targeting JPY 1 billion) announced on February 12, 2025. Furthermore, to maximize group synergies, the Company has begun reviewing the acquisition of all shares of Risenet Co., Ltd. (“Risenet”) which provides management‑support services to Rize Clinic and Gorilla Clinic. All Risenet shares are currently held by the Company’s CEO, Yoshiyuki Aikawa. Details—including acquisition price, closing schedule, and impact on consolidated financials of the Company—have not yet been determined. The Company will disclose material information promptly as decisions are made. About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchise clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and ...